Van Dijck, Anke
Barbosa, Susana
Bermudez-Martin, Patricia
Khalfallah, Olfa
Gilet, Cyprien
Martinuzzi, Emanuela
Elinck, Ellen
Kooy, R. Frank
Glaichenhaus, Nicolas
Davidovic, Laetitia
Funding for this research was provided by:
Fondation Jerome Lejeune
Agence nationale de la recherche (ANR JCJC SVE6 MetaboXFra)
Fragile X Foundation (FXS biomarkers)
Fragile X Foundation
Article History
Received: 31 July 2019
Accepted: 1 April 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: Collection of samples and data from Fragile X patients and healthy controls was approved by the medical ethics committee of the University of Antwerp in Belgium (Agreement #B300201523589). The study was conducted in accordance with statutes and regulations regarding the protection of the right and welfare of human subjects’ participation in biomedical research (World Declaration of Helsinki). Written informed consent was obtained from each participant or his/her legal guardian before research participation.
: Not applicable.
: The authors declare that they have no competing interests.